Share Name Share Symbol Market Type Share ISIN Share Description
Judges Scientific Plc LSE:JDG London Ordinary Share GB0032398678 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  100.00 1.25% 8,100.00 6,788 14:01:03
Bid Price Offer Price High Price Low Price Open Price
8,000.00 8,200.00 8,150.00 8,100.00 8,150.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Electronic & Electrical Equipment 91.29 14.86 201.00 40.3 512
Last Trade Time Trade Type Trade Size Trade Price Currency
17:54:36 O 858 8,200.82 GBX

Judges Scientific (JDG) Latest News (1)

More Judges Scientific News
Judges Scientific Investors    Judges Scientific Takeover Rumours

Judges Scientific (JDG) Discussions and Chat

Judges Scientific Forums and Chat

Date Time Title Posts
24/5/202209:54Judges Scientific - Scientific Instruments2,063
04/2/201515:50JUDGES CAPITAL:::::::Scientific Instruments15
01/3/200018:35Jordec - reversal into Vislink ?2

Add a New Thread

Judges Scientific (JDG) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Judges Scientific trades in real-time

Judges Scientific (JDG) Top Chat Posts

Judges Scientific Daily Update: Judges Scientific Plc is listed in the Electronic & Electrical Equipment sector of the London Stock Exchange with ticker JDG. The last closing price for Judges Scientific was 8,000p.
Judges Scientific Plc has a 4 week average price of 6,700p and a 12 week average price of 6,000p.
The 1 year high share price is 8,750p while the 1 year low share price is currently 5,740p.
There are currently 6,320,816 shares in issue and the average daily traded volume is 16,053 shares. The market capitalisation of Judges Scientific Plc is £511,986,096.
wad collector: Well the market certainly looks positively at the Geotek acquisition. From the outside, it is so hard to judge whether a price being paid is appropriate. Throw in a few words like synergism and visibility, and it sounds good. I like the following phrase; "Revenues tend to be lumpy". Let us hope that they are big lumps.
davidosh: David Cicurel will be at Mello2022 on Thursday to meet shareholders Mello2022, our annual flagship two day smaller growth company event will be returning to the popular Clayton Conference Centre in Chiswick, London W4 on Wednesday 25th May and Thursday 26th May. There will be 60+ LSE Small Cap and AIM listed companies attending including David Cicurel of Judges who has been a great supporter of Mello over the years and first came to present to our community in 2008. There will also be keynote speakers such as Lord John Lee, Andy Brough, Leon Boros, Clarke Carlisle and Gervais Williams. 1 day tickets are £115 and 2 day tickets are £189. However they are available at half price to shareholders so to obtain 50% off just use code MMTADVFN50. For more information, please visit the event webpage: Https://
cornishman33: JDG have acquired Geotek. This is the largest acquisition JDG have made and is expected to be materially earnings in the current financial year. Great news.👍
tomps2: Judges Scientific (JDG) full year 2021 results presentation - March 2022 CEO, David Cicurel, Group FD, Brad Ormsby & COO, Mark Lavelle present the full year 2021 results for the period ended 31 December 2021. The Group delivered record revenue, profits, cash generation and dividends in a year which still presented challenges as a consequence of the pandemic. Watch the video here: Or listen to the podcast here:
grahamburn: cornishman33. Agree with james188 - the busier ae bulletin board for a share, the poorer the quality of discourse plus the potential attaction for traders. This company is quiet and methodical in its execution which is exactly the right approach for its chosen market sector. It's true that the dividend is on the low side, but at least the promise of a 10% annual increase has been kept and, often, exceeded. Perhaps the only concern going forward is how long the company's driving force in the shape of David Cicurel will remain at the helm. At recent presentations he still seems highly motivated, so that's a good sign as well as the evidence that the other two executives are well-attuned to the business model and its execution.
james188: JDG is an excellent share, but not cheap and it is a low dividend payer, although the total return is first rate. I am very happy for it to attract less attention than many other AIM stocks.
cornishman33: Some large trades today, both buys and sells, in what is normally a very low volume share. No idea if this was significant or not. Results on the 23rd.
km18: ...from last year... Company overview: Judges Scientific is a group specialised in the acquisition and development of scientific instrument companies. The 19 firms currently under the umbrella are primarily UK-based with clients across the world. The acquisition strategy is a classic where they look for international portfolio of clients and sustainable sales and profits, nothing outstanding there. It seems to be working well for them as the goodwill figure is nicely kept at just above 20% of total assets, taking into consideration the fact that they have acquisitions every year in the past decade. On top of that, fundamentals are strong, with revenues growing at CAGR 7.28% and net profits are seeing 60% CAGR, which is impressive. Returns for investors are healthy, with ROCE standing at 17% for 2020 and rising at 15% CAGR and dividends continuously rising over the past 10 years, reaching 15.5p in 2020. There are some pension deficits that need further analysis, as they boost the gearing to 33.7%. Cash generation is strong with CFO rising in 6 of the last 10 years. The interim results released today look promising. Revenue is bumped by 14.7% to £43m and PBT is 55.4% ahead of 2020 interim at £6.7m. Net debt (adjusted for the IFRS 16) is significantly improved from £5.7m to £1.7m. The underlying theme is also very positive with organic intake increasing 25%  and even surpassing by 3% the record H1 2019. The company also secured £60m 5y bank facility to support acquisitions in the coming periods. Management expects the full year results to “exceed existing market expectations”. Short analysis: Cash cash has increase from December by 13.5%, due to strong CFO and a small issue of share capital Net debt decreased significantly to £1.7m CA/CL = 1.92 Cash ratio = 0.72 Interest coverage = 25.66 P/S TTM = 5.54, higher than the industry average BV ps = 605p, rising from 511p Operating profit is £7.1m, compared to £4.6m in H1 2020... .... from WealthOracleAM
alter ego: perhaps it's time for a share split. The spread can be horrible and must be a deterrent to buying or selling JDG stock. Would more volume traded help?
cornishman33: 'Order intake remains the main driver of performance and consequently the recovery in orders resulted in good progress in revenues. Organic revenue, which was 5% ahead in the first half, accelerated in the second half to reach double-digits for the year as a whole. As a result of the positive performance of the Group, the Board now anticipates that Adjusted Earnings Per Share for the full year ended 31 December 2021 will be ahead of market expectations' Excellent update. The share price is close to it's ath, maybe that could soon be taken out.
Judges Scientific share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Judges Sci..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220529 09:28:59